These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33044907)

  • 21. CRISPR/Cas9-based gene-editing technology for sickle cell disease.
    Ma L; Yang S; Peng Q; Zhang J; Zhang J
    Gene; 2023 Jul; 874():147480. PubMed ID: 37182559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Motivations and Decision-Making of Adult Sickle Cell Patients in High-Risk Clinical Research.
    Cho HL; Kim SYH; Fitzhugh C; Hsieh M; Tisdale J; Grady C
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1225-1232. PubMed ID: 32200120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Audio-visual presentation of information for informed consent for participation in clinical trials.
    Synnot A; Ryan R; Prictor M; Fetherstonhaugh D; Parker B
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD003717. PubMed ID: 24809816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sickle cell disease in western Sudan: genetic epidemiology and predictors of knowledge attitude and practices.
    Daak AA; Elsamani E; Ali EH; Mohamed FA; Abdel-Rahman ME; Elderdery AY; Talbot O; Kraft P; Ghebremeskel K; Elbashir MI; Fawzi W
    Trop Med Int Health; 2016 May; 21(5):642-53. PubMed ID: 27028397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supporting children and young people when making decisions about joining clinical trials: qualitative study to inform multimedia website development.
    Martin-Kerry JM; Knapp P; Atkin K; Bower P; Watt I; Stones C; Higgins S; Sheridan R; Preston J; Horton Taylor D; Baines P; Young B
    BMJ Open; 2019 Jan; 9(1):e023984. PubMed ID: 30782720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folate supplementation in people with sickle cell disease.
    Dixit R; Nettem S; Madan SS; Soe HHK; Abas AB; Vance LD; Stover PJ
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011130. PubMed ID: 29546732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimising informed consent for participants in a randomised controlled trial in rural Uganda: a comparative prospective cohort mixed-methods study.
    Ditai J; Kanyago J; Nambozo MR; Odeke NM; Abeso J; Dusabe-Richards J; Olupot-Olupot P; Carrol ED; Medina-Lara A; Gladstone M; Storr J; Faragher B; Weeks AD
    Trials; 2018 Dec; 19(1):699. PubMed ID: 30577809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving informed consent: Stakeholder views.
    Anderson EE; Newman SB; Matthews AK
    AJOB Empir Bioeth; 2017; 8(3):178-188. PubMed ID: 28949896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Communication with children about sickle cell disease: A qualitative study of parent experience.
    Middleton J; Calam R; Ulph F
    Br J Health Psychol; 2018 Sep; 23(3):685-700. PubMed ID: 29885041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A justice-based argument for including sickle cell disease in CRISPR/Cas9 clinical research.
    Baffoe-Bonnie MS
    Bioethics; 2019 Jul; 33(6):661-668. PubMed ID: 31107563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of Factors Associated With Parental Perceptions of Voluntary Decisions About Child Participation in Leukemia Clinical Trials.
    Aristizabal P; Ma AK; Kumar NV; Perdomo BP; Thornburg CD; Martinez ME; Nodora J
    JAMA Netw Open; 2021 May; 4(5):e219038. PubMed ID: 33944924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells.
    DeWitt MA; Magis W; Bray NL; Wang T; Berman JR; Urbinati F; Heo SJ; Mitros T; Muñoz DP; Boffelli D; Kohn DB; Walters MC; Carroll D; Martin DI; Corn JE
    Sci Transl Med; 2016 Oct; 8(360):360ra134. PubMed ID: 27733558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Audio-visual presentation of information for informed consent for participation in clinical trials.
    Ryan RE; Prictor MJ; McLaughlin KJ; Hill SJ
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003717. PubMed ID: 18254029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Cas9 Hammer-and Sickle: A Challenge for Genome Editors.
    Urnov FD
    CRISPR J; 2021 Feb; 4(1):6-13. PubMed ID: 33616446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease.
    Park SH; Lee CM; Dever DP; Davis TH; Camarena J; Srifa W; Zhang Y; Paikari A; Chang AK; Porteus MH; Sheehan VA; Bao G
    Nucleic Acids Res; 2019 Sep; 47(15):7955-7972. PubMed ID: 31147717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients' Views Concerning Research on Medical Practices: Implications for Consent.
    Weinfurt KP; Bollinger JM; Brelsford KM; Crayton TJ; Topazian RJ; Kass NE; Beskow LM; Sugarman J
    AJOB Empir Bioeth; 2016; 7(2):76-91. PubMed ID: 27800531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood.
    Hankins JS; Estepp JH; Hodges JR; Villavicencio MA; Robison LL; Weiss MJ; Kang G; Schreiber JE; Porter JS; Kaste SC; Saving KL; Bryant PC; Deyo JE; Nottage KA; King AA; Brandow AM; Lebensburger JD; Adesina O; Chou ST; Zemel BS; Smeltzer MP; Wang WC; Gurney JG
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27228. PubMed ID: 29797644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective therapies for sickle cell disease: are we there yet?
    Crossley M; Christakopoulos GE; Weiss MJ
    Trends Genet; 2022 Dec; 38(12):1284-1298. PubMed ID: 35934593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.
    Snyder AB; Lakshmanan S; Hulihan MM; Paulukonis ST; Zhou M; Horiuchi SS; Abe K; Pope SN; Schieve LA
    MMWR Surveill Summ; 2022 Oct; 71(9):1-18. PubMed ID: 36201430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.